abstract |
The present invention relates to a controlled-release pharmaceutical composition comprisingnat least one active agent and an inactive matrix, said matrix comprising chitosan andnderivatives thereof, and further comprising a hydrophilic polysaccharide polymer selectednfrom the group of carbohydrate gums, specifically xanthan gum, and to the preparation andnuse of said composition. |